Prednisolone Sodium Phosphate Solution
NDC Package 63548-5320-0

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Prednisolone Sodium Phosphate solution is prednisolone is used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. This formulation utilizes a solution delivery system. Marketed by Pld Acquisitions Llc Dba Av�ma Pharma Solutions, this product is identified by NDC 63548-5320.

Identification & Billing

NDC Package Code
63548-5320-0
Package Description
237 mL in 1 BOTTLE, PLASTIC
Product Code
63548-5320
11-Digit Billing Format
63548532000

Clinical Specifications

Proprietary Name
Prednisolone Sodium Phosphate
Non-Proprietary Name
Prednisolone Sodium Phosphate
Substance Name
Prednisolone Sodium Phosphate
Dosage Form
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Active Ingredient(s)
PREDNISOLONE SODIUM PHOSPHATE 25 mg/5mL
Usage Information
Prednisolone is used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. It decreases your immune system's response to various diseases to reduce symptoms such as swelling, pain and allergic-type reactions. This medication is a corticosteroid hormone. Prednisolone may also be used with other medications in hormone disorders.

Regulatory & Marketing

Labeler Name
Pld Acquisitions Llc Dba Av�ma Pharma Solutions
Product Type
Bulk Ingredient
Marketing Category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING - A category specifying that a bulk product is intended for use on humans and requires a prescription.
Start Marketing Date
03-15-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 63548-5320-0 identifies a specific commercial package of 237 ml in 1 bottle, plastic of Prednisolone Sodium Phosphate (UNFINISHED drug), a bulk ingredient labeled by Pld Acquisitions Llc Dba Av�ma Pharma Solutions. This solution is formulated for use and contains prednisolone sodium phosphate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Pld Acquisitions Llc Dba Av�ma Pharma Solutions on March 15, 2025. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Prednisolone is used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. It decreases your immune system's response to various diseases to reduce symptoms such as swelling, pain and allergic-type reactions. This medication is a corticosteroid hormone. Prednisolone may also be used with other medications in hormone disorders.

How is this Pld Acquisitions Llc Dba Av�ma Pharma Solutions product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 63548532000. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
63548-5320-0
11-Digit CMS (5-4-2)
63548-5320-00

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.